Shenghao Li
-
- Cancer, Hypoxia, and Metabolism 4
-
- Hippo pathway signaling and YAP/TAZ 3
-
- Hepatitis C virus research 3
-
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 3
-
- Cancer Immunotherapy and Biomarkers 4
-
- Ferroptosis and cancer prognosis 3
-
- Immune cells in cancer 3
- Co-authors
- Liyuan HaoXinli ShiJiali DengJunli ZhangQing PengLi WangJingmin JiHui Li
In The Last Decade
Shenghao Li
32 papers receiving 369 citations
Peers
Comparison fields: 5 of 72
- Biochemistry 17
- Cancer Research 42
- Molecular Biology 166
- Cell Biology 37
- Hepatology 17
Countries citing papers authored by Shenghao Li
This map shows the geographic impact of Shenghao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghao Li more than expected).
Fields of papers citing papers by Shenghao Li
This network shows the impact of papers produced by Shenghao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghao Li. The network helps show where Shenghao Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shenghao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 22 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 12 | |
| 15 | 2023 | 14 | |
| 16 | 2022 | 8 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 19 | |
| 19 | 2020 | 36 | |
| 20 | 2018 | 47 |
About Shenghao Li
Shenghao Li is a scholar working on Hepatology, Applied Microbiology and Biotechnology and Epidemiology, having authored 33 papers that have together received 373 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (3 papers), Hepatitis B Virus Studies (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Immune cells in cancer (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Biochemistry (17 citations), Cancer Research (42 citations) and Molecular Biology (166 citations). Shenghao Li has collaborated with scholars based in China, Croatia and Singapore. Frequent co-authors include Liyuan Hao, Xinli Shi, Jiali Deng, Junli Zhang, Qing Peng, Li Wang, Jingmin Ji, Hui Li, Jianchun Li and Zhen Li. Their work appears in journals such as Scientific Reports, ACS Catalysis and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.